Loading provider…
Loading provider…
Cardiovascular Disease Physician in Saint Louis, MO
NPI: 1649298118Primary Practice Location
BARNES JEWISH HOSPITAL
1 Barnes Jewish Hospital Plz, Saint Louis, MO
Primary Employer
Washington University School of Medicine
surgery.wustl.edu
HQ Phone
Get MD Ronald's Phone Numberphone_androidMobile
Get MD Ronald's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMO State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 93010Routine electrocardiogram (EKG) using at least 12 leads with interpretation and report | 2,568 | 3,776 |
| 2 | G0422Intensive cardiac rehabilitation; with or without continuous ecg monitoring with exercise, per session | 125 | 568 |
| 3 | G0423Intensive cardiac rehabilitation; with or without continuous ecg monitoring; without exercise, per session | 118 | 480 |
| 4 | 93244Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 61 | 62 |
| 5 | 94618Test for exercise-induced lung stress | 55 | 120 |
Authors: Kalon Ho, Jeptha Curtis, Eric Peterson, Susan Fitzgerald, Mandeep Singh
Journal: JACC Cardiovasc Interv
Clinical and angiographic risk stratification and differential impact on treatment outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
Authors: Edward Sako, Robert Frye, Frederick Feit, Bernard Gersh
Publication Date: 2012-09-26
Senior academic physicians and retirement considerations.
Authors: Henry Greenberg, Mark Haigney, Robert Goldstein, Monty Bodenheimer, John Gillespie, Edward Dwyer, Charles Francis
Journal: Prog Cardiovasc Dis
Publication Date: 2013-03-21
Lead Sponsor: Washington University School of Medicine
Intervention / Treatment: DRUG: Doxorubicin, DRUG: Dexrazoxane
Lead Sponsor: University of Rochester
Collaborators: Boston Scientific Corporation
Intervention / Treatment: DEVICE: Three-lead CRT-D (Defibrillator)